Results 171 to 180 of about 5,926,898 (305)

WAYS TO REFORM FOR COMPULSORY MEDICAL INSURANCE FUND IN RUSSIA

open access: yesSovremennye issledovaniya sotsialnykh problem, 2015
Natalia Ivanovna Lyakhova   +1 more
openaire   +1 more source

Other title: Kansas Insurance Department news release, 2002; Other title: Kansas Insurance Commissioner: for immediate release, 2002

open access: yes, 2002
application/pdf; Annual cumulation of 2002 issuesKansas Drivers Get Winter Accident Checklist -- Sebelius Denies Anthem of Indianas Takeover of Blue Cross and Blue Shield of Kansas -- Sebelius reminds Kansans to get insurance in order before stormsstrike;
Kansas. Insurance Department.
core  

A Pragmatic Trial of a Shared Decision‐Making Intervention to Improve Medication Adherence and Outcomes in Systemic Lupus Erythematosus: The HCQ‐SAFE Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective Hydroxychloroquine (HCQ) nonadherence in systemic lupus erythematosus (SLE) stemming from decision complexities can be improved with shared decision‐making (SDM) tools clarifying benefits and harms. This study aimed to develop and evaluate HCQ‐SAFE, a pictogram‐based SDM tool during SLE visits.
Caroline Packee   +8 more
wiley   +1 more source

Oregon Medical Insurance Pool, plan 1500

open access: yes, 2007
This archived document is maintained by the Oregon State Library as part of the Oregon Documents Depository Program. It is for informational purposes and may not be suitable for legal purposes.Title from PDF cover (viewed on Oct. 2, 2008)"440-3940 (1/07)

core  

Fine Particulate Matter Constituents, Ozone, and Systemic Lupus Erythematosus: A Large General‐Population Cohort Analysis With Extended Quantile g‐Computation

open access: yesArthritis &Rheumatology, EarlyView.
Objective The aim of this study was to investigate whether exposure to mixture of individual fine particulate matter (PM2.5) chemical constituents is associated with incident systemic lupus erythematosus (SLE) and if ozone modifies this association and/or is associated with SLE onset.
Naizhuo Zhao   +9 more
wiley   +1 more source

Nonmelanoma Skin Cancer Risk With JAK Inhibitors Compared to Interleukin‐6 Receptor Inhibitors in Rheumatoid Arthritis: Results From a National Cohort Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective Nonmelanoma skin cancer (NMSC) is one of the most common malignancies in rheumatoid arthritis (RA). This analysis assessed NMSC risk with JAK inhibitors (JAKi) compared to interleukin‐6 receptor inhibitors (IL‐6Ri). Methods This study used data from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis linked to the
Zixing Tian   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy